SCHEMBL42937

SCHEMBL42937

CCCOC(=O)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18776185 0.86 EPHX1 (0.59)
SCHEMBL16342091 0.86 EPHX1 (0.59)
SCHEMBL16541245 0.86 CHRNB2 (0.65)
SCHEMBL968307 0.85
SCHEMBL1170169 0.83 EPHX1 (0.96)
SCHEMBL25270995 0.81 EPHX1 (1.00)
SCHEMBL4616449 0.81 EPHX1 (1.00)
SCHEMBL10816925 0.81 EPHX1 (1.00)
SCHEMBL11319803 0.81 EPHX1 (1.00)
SCHEMBL12635224 0.81 EPHX1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113951251-B NKT cell preservation solution and preservation method 广州希灵生物科技有限公司 2022-06-28 CN claimed
CN-113951251-A NKT cell preservation solution and preservation method 李颜军 2022-01-21 CN claimed
CN-108715729-B Preparation method of flame-retardant antibacterial waterborne polyurethane coating and adhesive 浙江伟涛包装材料有限公司 2021-06-08 CN claimed
US-8101620-B2 Heterocyclic sulfonamides CYTOKINETICS, INC. (US) 2012-01-24 US claimed
US-20110112154-A1 Compounds, compositions and methods CYTOKINETICS, INC. 2011-05-12 US claimed
US-7312200-B2 9-ketospinosyn derivatives BAYER CROPSCIENCE AG (DE) 2007-12-25 US claimed
US-20060128642-A1 9-Ketospinosyn derivatives BAYER CROPSCIENCE AG (DE) 2006-06-15 US claimed
CN-1784416-A 9-ketospinosyn derivatives BAYER CROPSCIENCE AG (DE) 2006-06-07 CN claimed
CN-1780823-A Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC (JP) 2006-05-31 CN claimed
EP-1590358-A1 9-KETOSPINOSYN DERIVATIVES Bayer CropScience Aktiengesellschaft (DE) 2005-11-02 EP claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2004065402-A1 9-KETOSPINOSYN DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2004-08-05 WO claimed
EP-1140895-B1 THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP FUJISAWA PHARMACEUTICAL CO (JP) 2004-03-24 EP claimed
WO-2003018019-A2 NEW USE OF CYCLIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-03-06 WO claimed
EP-1140895-A2 THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-10 EP claimed
WO-2000040576-A2 THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-13 WO claimed
EP-0450039-A1 DIHYDRO-1,2 OXO-2 QUINOXALINE DERIVATES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS. FABRE PIERRE COSMETIQUE (FR) 1991-10-09 EP claimed
EP-4446310-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND Asahi Kasei Kabushiki Kaisha (JP) 2024-10-16 EP disclosed
US-4284631-A 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-08-18 US disclosed
EP-0007633-A2 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-02-06 EP disclosed